Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $50.4400 (1.88%) ($50.4400 - $50.4500) on Mon. Jul. 25, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.72% (three month average) | RSI | 64 | Latest Price | $50.4400(1.88%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.9% a day on average for past five trading days. | Weekly Trend | HALO advances 1.2% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(41%) IWM(36%) IWO(36%) IWN(35%) IFRA(34%) | Factors Impacting HALO price | HALO will decline at least -1.36% in a week (0% probabilities). VIXM(-14%) UUP(-8%) EDOC(-7%) VXX(-6%) TBT(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.36% (StdDev 2.72%) | Hourly BBV | 0.5 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $50.12(0.64%) | 10 Day Moving Average | $49.36(2.19%) | 20 Day Moving Average | $48.33(4.37%) | To recent high | -2.6% | To recent low | 35% | Market Cap | $6.894b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |